Perspective Therapeutics CATX Liabilities held for sale
Liabilities held for sale at other companies
Other financials
Where this comes from
Reported directly by Perspective Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent.
The official record: Perspective Therapeutics’s 10-K/A, filed March 28, 2025, on SEC EDGAR. View the filing →
Ask your AI about Perspective Therapeutics's liabilities held for sale.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Perspective Therapeutics's liabilities held for sale?
- Perspective Therapeutics (CATX) reported liabilities held for sale of $0 in Q4 2024.
- How has Perspective Therapeutics's liabilities held for sale changed year-over-year?
- Perspective Therapeutics's liabilities held for sale decreased by 100.0% year-over-year, from $5.07M to $0.
- What is the long-term trend for Perspective Therapeutics's liabilities held for sale?
- Over 2 years (2022 to 2024), Perspective Therapeutics's liabilities held for sale has grown at a -100.0% compound annual growth rate (CAGR), from $276K to $0.
- What does liabilities held for sale mean?
- Liabilities associated with disposal groups classified as held for sale, presented separately on the balance sheet.